Management of postmenopausal osteoporosis

Marie A. Chisholm, Anthony L. Mulloy, Jasvir Singh

Research output: Contribution to journalReview article

Abstract

Osteoporosis, a reduction in bone mass density, is the most common skeletal disorder of the elderly. This crippling disease causes greater than 1.5 million fractures each year, with annual costs to the U.S. health care system of approximately $14 billion. Osteoporotic fractures cause pain, disability, and, in some cases, death. Although osteoporosis is a preventable and treatable condition, many postmenopausal women with osteoporosis are unaware of their fragile skeletal condition until fractures occur. Early diagnosis of osteoporosis is possible by measuring bone density and by targeting those at greatest risk of developing osteoporotic fractures. Treatment with calcium, estrogen, raloxifene, calcitonin, or alendronate stabilizes bone density in the elderly and reduces the risk of fractures. This article reviews the current strategies for evaluation, diagnosis, and management of osteoporosis.

Original languageEnglish (US)
Pages (from-to)3-20
Number of pages18
JournalJournal of Geriatric Drug Therapy
Volume12
Issue number4
DOIs
StatePublished - Jan 1 1999

Fingerprint

Postmenopausal Osteoporosis
Osteoporosis
Bone Density
Osteoporotic Fractures
Alendronate
Calcitonin
Early Diagnosis
Estrogens
Calcium
Delivery of Health Care
Costs and Cost Analysis
Pain

Keywords

  • Elderly
  • Pharmacotherapy of postmenopausal osteoporosis
  • Postmenopausal osteoporosis

ASJC Scopus subject areas

  • Geriatrics and Gerontology
  • Pharmacology (medical)

Cite this

Management of postmenopausal osteoporosis. / Chisholm, Marie A.; Mulloy, Anthony L.; Singh, Jasvir.

In: Journal of Geriatric Drug Therapy, Vol. 12, No. 4, 01.01.1999, p. 3-20.

Research output: Contribution to journalReview article

Chisholm, Marie A. ; Mulloy, Anthony L. ; Singh, Jasvir. / Management of postmenopausal osteoporosis. In: Journal of Geriatric Drug Therapy. 1999 ; Vol. 12, No. 4. pp. 3-20.
@article{b7dd0a59e2424aae8b29b613d58eaa2e,
title = "Management of postmenopausal osteoporosis",
abstract = "Osteoporosis, a reduction in bone mass density, is the most common skeletal disorder of the elderly. This crippling disease causes greater than 1.5 million fractures each year, with annual costs to the U.S. health care system of approximately $14 billion. Osteoporotic fractures cause pain, disability, and, in some cases, death. Although osteoporosis is a preventable and treatable condition, many postmenopausal women with osteoporosis are unaware of their fragile skeletal condition until fractures occur. Early diagnosis of osteoporosis is possible by measuring bone density and by targeting those at greatest risk of developing osteoporotic fractures. Treatment with calcium, estrogen, raloxifene, calcitonin, or alendronate stabilizes bone density in the elderly and reduces the risk of fractures. This article reviews the current strategies for evaluation, diagnosis, and management of osteoporosis.",
keywords = "Elderly, Pharmacotherapy of postmenopausal osteoporosis, Postmenopausal osteoporosis",
author = "Chisholm, {Marie A.} and Mulloy, {Anthony L.} and Jasvir Singh",
year = "1999",
month = "1",
day = "1",
doi = "10.1300/J089v12n04_01",
language = "English (US)",
volume = "12",
pages = "3--20",
journal = "Journal of Geriatric Drug Therapy",
issn = "8756-4629",
publisher = "Haworth Press Inc.",
number = "4",

}

TY - JOUR

T1 - Management of postmenopausal osteoporosis

AU - Chisholm, Marie A.

AU - Mulloy, Anthony L.

AU - Singh, Jasvir

PY - 1999/1/1

Y1 - 1999/1/1

N2 - Osteoporosis, a reduction in bone mass density, is the most common skeletal disorder of the elderly. This crippling disease causes greater than 1.5 million fractures each year, with annual costs to the U.S. health care system of approximately $14 billion. Osteoporotic fractures cause pain, disability, and, in some cases, death. Although osteoporosis is a preventable and treatable condition, many postmenopausal women with osteoporosis are unaware of their fragile skeletal condition until fractures occur. Early diagnosis of osteoporosis is possible by measuring bone density and by targeting those at greatest risk of developing osteoporotic fractures. Treatment with calcium, estrogen, raloxifene, calcitonin, or alendronate stabilizes bone density in the elderly and reduces the risk of fractures. This article reviews the current strategies for evaluation, diagnosis, and management of osteoporosis.

AB - Osteoporosis, a reduction in bone mass density, is the most common skeletal disorder of the elderly. This crippling disease causes greater than 1.5 million fractures each year, with annual costs to the U.S. health care system of approximately $14 billion. Osteoporotic fractures cause pain, disability, and, in some cases, death. Although osteoporosis is a preventable and treatable condition, many postmenopausal women with osteoporosis are unaware of their fragile skeletal condition until fractures occur. Early diagnosis of osteoporosis is possible by measuring bone density and by targeting those at greatest risk of developing osteoporotic fractures. Treatment with calcium, estrogen, raloxifene, calcitonin, or alendronate stabilizes bone density in the elderly and reduces the risk of fractures. This article reviews the current strategies for evaluation, diagnosis, and management of osteoporosis.

KW - Elderly

KW - Pharmacotherapy of postmenopausal osteoporosis

KW - Postmenopausal osteoporosis

UR - http://www.scopus.com/inward/record.url?scp=0033303323&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033303323&partnerID=8YFLogxK

U2 - 10.1300/J089v12n04_01

DO - 10.1300/J089v12n04_01

M3 - Review article

AN - SCOPUS:0033303323

VL - 12

SP - 3

EP - 20

JO - Journal of Geriatric Drug Therapy

JF - Journal of Geriatric Drug Therapy

SN - 8756-4629

IS - 4

ER -